August 19, 2016 / 12:27 PM / a year ago

BRIEF-Spectral expects to release primary end point results for pivotal Euphrates after end of Q3

Aug 19 (Reuters) - Spectral Medical Inc

* Spectral unaware of any material change

* Expects to release primary end point results for pivotal Euphrates trial immediately after end of Q3 ended September 30, 2016

* Confirms it is unaware of any material, undisclosed corporate developments that would account for recent decrease in its share price Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below